These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34749819)

  • 1. Sex differences in the expression of the endocannabinoid system within V1M cortex and PAG of Sprague Dawley rats.
    Levine A; Liktor-Busa E; Lipinski AA; Couture S; Balasubramanian S; Aicher SA; Langlais PR; Vanderah TW; Largent-Milnes TM
    Biol Sex Differ; 2021 Nov; 12(1):60. PubMed ID: 34749819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey.
    Lau BK; Drew GM; Mitchell VA; Vaughan CW
    Br J Pharmacol; 2014 Dec; 171(23):5225-36. PubMed ID: 25041240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexually Dimorphic Expression of Fear-conditioned Analgesia in Rats and Associated Alterations in the Endocannabinoid System in the Periaqueductal Grey.
    Llorente-Berzal A; McGowan F; Gaspar JC; Rea K; Roche M; Finn DP
    Neuroscience; 2022 Jan; 480():117-130. PubMed ID: 34774710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
    Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V
    J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoids control vesicle release mode at midbrain periaqueductal grey inhibitory synapses.
    Aubrey KR; Drew GM; Jeong HJ; Lau BK; Vaughan CW
    J Physiol; 2017 Jan; 595(1):165-178. PubMed ID: 27461371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of type 5 metabotropic glutamate receptors and diacylglycerol lipase-α initiates 2-arachidonoylglycerol formation and endocannabinoid-mediated analgesia.
    Gregg LC; Jung KM; Spradley JM; Nyilas R; Suplita RL; Zimmer A; Watanabe M; Mackie K; Katona I; Piomelli D; Hohmann AG
    J Neurosci; 2012 Jul; 32(28):9457-68. PubMed ID: 22787031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences.
    Noya-Riobó MV; Miguel CÁ; Soriano DB; Brumovsky PR; Villar MJ; Coronel MF
    Exp Neurol; 2023 Jan; 359():114232. PubMed ID: 36179876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey.
    Mitchell VA; Kawahara H; Vaughan CW
    J Physiol; 2009 Jun; 587(Pt 11):2511-20. PubMed ID: 19359367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoacylglycerol Lipase Protects the Presynaptic Cannabinoid 1 Receptor from Desensitization by Endocannabinoids after Persistent Inflammation.
    Bouchet CA; McPherson KB; Coutens B; Janowsky A; Ingram SL
    J Neurosci; 2023 Jul; 43(30):5458-5467. PubMed ID: 37414560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABHD6 and MAGL control 2-AG levels in the PAG and allodynia in a CSD-induced periorbital model of headache.
    Liktor-Busa E; Levine AA; Palomino SM; Singh S; Wahl J; Vanderah TW; Stella N; Largent-Milnes TM
    Front Pain Res (Lausanne); 2023; 4():1171188. PubMed ID: 37287623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DAGLα Inhibition as a Non-invasive and Translational Model of Episodic Headache.
    Levine A; Liktor-Busa E; Karlage KL; Giancotti L; Salvemini D; Vanderah TW; Largent-Milnes TM
    Front Pharmacol; 2020; 11():615028. PubMed ID: 33584293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of 2-AG hydrolysis alleviates posttraumatic headache attributed to mild traumatic brain injury.
    Wen J; Tanaka M; Zhang Y
    J Headache Pain; 2024 Jul; 25(1):115. PubMed ID: 39014318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone.
    Olango WM; Roche M; Ford GK; Harhen B; Finn DP
    Br J Pharmacol; 2012 Apr; 165(8):2549-60. PubMed ID: 21564082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of brain endocannabinoid levels by voluntary alcohol consumption in alcohol-preferring AA rats.
    Malinen H; Lehtonen M; Hyytiä P
    Alcohol Clin Exp Res; 2009 Oct; 33(10):1711-20. PubMed ID: 19572983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamate spillover modulates GABAergic synaptic transmission in the rat midbrain periaqueductal grey via metabotropic glutamate receptors and endocannabinoid signaling.
    Drew GM; Mitchell VA; Vaughan CW
    J Neurosci; 2008 Jan; 28(4):808-15. PubMed ID: 18216189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin exerts an effect via the endocannabinoid system to inhibit GABAergic transmission in midbrain periaqueductal gray.
    Mitchell VA; Jeong HJ; Drew GM; Vaughan CW
    Neuropsychopharmacology; 2011 Aug; 36(9):1801-10. PubMed ID: 21525858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study on the correlation of the asymmetric regulation between the periaqueductal gray and the bilateral trigeminal nucleus caudalis in migraine male rats.
    Cao Z; Yu W; Zhang L; Yang J; Lou J; Xu M; Zhang Z
    J Headache Pain; 2023 Mar; 24(1):27. PubMed ID: 36935501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia.
    Suplita RL; Gutierrez T; Fegley D; Piomelli D; Hohmann AG
    Neuropharmacology; 2006 Mar; 50(3):372-9. PubMed ID: 16316669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.